Khanlou H - Search Results

1

Avoid a different standard of care when applying results of Development of Antiretroviral Therapy in Africa (DART) study.

Sayana S, Manchanda R, Khanlou H, Saavedra J, Reis P, Weinstein M. Sayana S, et al. Among authors: khanlou h. J Acquir Immune Defic Syndr. 2010 Jan;53(1):153-4. doi: 10.1097/QAI.0b013e3181c79be7. J Acquir Immune Defic Syndr. 2010. PMID: 20035167 No abstract available.

2

DART and laboratory monitoring of HIV treatment.

Sayana S, Manchanda R, Khanlou H, Saavedra J, Reis P, Weinstein M. Sayana S, et al. Among authors: khanlou h. Lancet. 2010 Mar 20;375(9719):979; author reply 979-80. doi: 10.1016/S0140-6736(10)60430-8. Lancet. 2010. PMID: 20304235 No abstract available.

3

Clinical impact and cost of laboratory monitoring need review even in resource-rich setting.

Sayana S, Javanbakht M, Weinstein M, Khanlou H. Sayana S, et al. Among authors: khanlou h. J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):e97-8. doi: 10.1097/QAI.0b013e31820472e8. J Acquir Immune Defic Syndr. 2011. PMID: 21317583 No abstract available.

4

The 104 day report: a successful intervention of improving patient retention.

Sayana S, Javanbakht M, Weinstein M, Khanlou H. Sayana S, et al. Among authors: khanlou h. Clin Infect Dis. 2010 Oct 1;51(7):868-9. doi: 10.1086/656291. Clin Infect Dis. 2010. PMID: 20809839 No abstract available.

5

Raltegravir: the first in a new class of integrase inhibitors for the treatment of HIV.

Sayana S, Khanlou H. Sayana S, et al. Among authors: khanlou h. Expert Rev Anti Infect Ther. 2008 Aug;6(4):419-26. doi: 10.1586/14787210.6.4.419. Expert Rev Anti Infect Ther. 2008. PMID: 18662108 Review.

6

Maraviroc: a new CCR5 antagonist.

Sayana S, Khanlou H. Sayana S, et al. Among authors: khanlou h. Expert Rev Anti Infect Ther. 2009 Feb;7(1):9-19. doi: 10.1586/14787210.7.1.9. Expert Rev Anti Infect Ther. 2009. PMID: 19622053 Review.

7

Use of maraviroc-, raltegravir-, and etravirine-containing regimens in treatment-experienced patients: a case-series study.

Youngblood C, Sayana S, Khanlou H. Youngblood C, et al. Among authors: khanlou h. J Int Assoc Physicians AIDS Care (Chic). 2011 May-Jun;10(3):135-7. doi: 10.1177/1545109710393311. Epub 2011 Mar 23. J Int Assoc Physicians AIDS Care (Chic). 2011. PMID: 21430236

8

No residual activity of raltegravir after development of 148 complex mutations in vivo.

Khanlou H, Sayana S, Acosta E. Khanlou H, et al. J Int Assoc Physicians AIDS Care (Chic). 2008 Nov-Dec;7(6):281-2. doi: 10.1177/1545109708327489. J Int Assoc Physicians AIDS Care (Chic). 2008. PMID: 19164138 No abstract available.

9

An unusual pathogen for a liver abscess in a human immunodeficiency virus-infected individual.

Sayana S, Ricaurte JC, Khanlou H. Sayana S, et al. Among authors: khanlou h. Am J Med Sci. 2010 Mar;339(3):290-1. doi: 10.1097/MAJ.0b013e3181c6ef05. Am J Med Sci. 2010. PMID: 20220339

10

Meningitis due to hematogenous dissemination of community-associated methicillin-resistant Staphylococcus aureus (MRSA) in a patient with AIDS.

Sayana S, Khanlou H. Sayana S, et al. Among authors: khanlou h. J Int Assoc Physicians AIDS Care (Chic). 2008 Nov-Dec;7(6):289-91. doi: 10.1177/1545109708326089. Epub 2008 Oct 20. J Int Assoc Physicians AIDS Care (Chic). 2008. PMID: 18936290

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters